Developing and deploying intratumoral cancer immunotherapy with AS01B combined with autologous myeloid dendritic cells and natural killer cells

Activity: Other › Written proposal

Description

Wrote an FWO application, selected for second round
Period1 Jan 2023 → 1 Oct 2023
Held atResearch Foundation Flanders, Belgium
Degree of RecognitionNational